Here’s how Moderna is thinking about the future of its vaccines
Moderna laid out its expectations for several vaccine markets Wednesday morning at an investor event as it continues moving through its “year of transition.” A team of execs outlined a potential $52 billion vaccines market at its peak, according to Moderna’s estimates. Roughly half of that would come from a